KOSDAQ Stocks Outperform with Strong Gains Above 50%
Three standout performers on South Korea’s tech-focused KOSDAQ market—HLB, SPG, and Peptron—have each climbed more than 50% in the past month. This renewed interest in smaller cap stocks reflects a notable capital rotation as investors move away from the main board KOSPI index, which has suffered a significant downturn. The KOSDAQ’s focus on mid-to-small cap companies in biotech, precision machinery, and emerging technologies has positioned it well amid targeted innovation sector developments.
KOSPI Suffers Sharp Decline Driven by Regulatory and Sector Headwinds
The benchmark KOSPI index plunged 22% in July, marking one of its steepest monthly declines in recent years. After reaching a historic peak on July 22, the index retraced roughly 34% before rebounding nearly 18% in a single day at the month’s end. However, volatility remains elevated and market confidence fragile. South Korean regulators tightened margin requirements for leveraged ETFs linked to large-cap stocks Samsung Electronics and SK Hynix, raising minimum collateral from 10 million KRW to 30 million KRW. This move aimed at curbing speculative trading has been a key factor suppressing the main board’s recovery. Simultaneously, the global AI sector’s adjustment phase has weighed on semiconductor shares, with SK Hynix and Samsung Electronics sliding 14.65% and over 13% respectively at July’s close.
Investors Shift Gears to KOSDAQ Innovators
While KOSPI endures pressure, the KOSDAQ index has maintained an upward trajectory since early August, logging gains over five consecutive sessions. The rally centers on three companies unveiling positive catalysts:
HLB: Its cancer drug Rivoceranib faced three FDA rejections largely tied to production issues at a Chinese manufacturing partner. On July 15, the FDA confirmed completion of remedial measures, triggering a near 30% single-day surge in HLB’s shares.
SPG: As a producer of precision reducers and motors, SPG is making strides in humanoid robot actuator technology. IBK Securities highlights SPG's exclusive comprehensive humanoid-grade precision reducer line, currently supplying Rainbow Robotics and negotiating with U.S. companies.
Peptron: Peptron’s stock has climbed since August, fueled by speculation regarding its potential to become a domestic supplier for Eli Lilly’s GLP-1 long-acting obesity medication. Although formal supply agreements remain unannounced, market expectations for Peptron’s role in this supply chain have risen.
Market Dynamics Reflect Structural Shifts and Heightened Regulatory Oversight
Morgan Stanley’s recent upgrade of the KOSPI suggests some investors interpret the index’s selloff as a prospective buying opportunity. Nevertheless, the sustainability of capital flows into KOSDAQ depends partly on the main board’s recovery pace. The tightened regulatory framework for leveraged ETFs has sharply reduced related trading volumes, effectively dampening KOSPI volatility. Conversely, the KOSDAQ rebound underscores growing investor interest in innovation-driven sectors.
Overall, South Korea’s equity markets are undergoing a structural realignment with pronounced divergence between large-cap and growth-oriented small-cap segments. Market participants remain attentive to evolving macroprudential policies and developments within the global AI and semiconductor landscape.